FHA
TBIO

Flagship Harbor Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Flagship Harbor Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,080
Closed -$28K – 1959
2020
Q3 		$28K Hold
2,080
– – ﹤0.01% 1041
2020
Q2 		$37K Buy
+2,080
New +$31.4K 0.01% 944

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Flagship Harbor Advisors's TBIO Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q4 2020, closing a stake of 2,080 shares — an estimated $28K sold.

Flagship Harbor Advisors first reported a position in TBIO in Q2 2020 and held it in 2 quarters. The position peaked at $37K in Q2 2020. 150 funds tracked by Wall St. Rank hold TBIO as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 2,080 Translate Bio, Inc. Common Stock shares in Q4 2020, an estimated $28K.
  • Flagship Harbor Advisors first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Flagship Harbor Advisors's Translate Bio, Inc. Common Stock position peaked at $37K in Q2 2020.
  • 150 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.